Soy Isoflavones vs Red Clover for Perimenopause: Which Phytoestrogen Works Better?
Soy isoflavones and red clover are both used for perimenopause hot flashes. Compare the evidence, doses, and safety to find the better option for you.
Phytoestrogens as a Perimenopause Option
Phytoestrogens are plant compounds that weakly bind to oestrogen receptors in the body. They have attracted interest as a natural alternative or complement to hormone replacement therapy for women who cannot take or prefer not to take conventional HRT. Two of the most studied and widely used phytoestrogen sources are soy isoflavones and red clover isoflavones. Both contain compounds in the isoflavone family, but they differ in their specific isoflavone profiles, the evidence supporting them, and some practical aspects of use. Comparing them clearly can help women make a more informed choice.
Soy Isoflavones: The Evidence
Soy isoflavones are derived from soya beans and contain primarily genistein and daidzein. Multiple randomised trials and meta-analyses have examined their effect on hot flashes, with results that are consistently positive but modest. A typical finding is a reduction in hot flash frequency of around 20 to 30 percent compared to placebo, with some individual women responding much more strongly, particularly those whose gut bacteria can convert daidzein into equol, a more active form. Soy isoflavones are also associated with modest improvements in cholesterol profiles, bone density markers, and cognitive function in some studies. Foods high in soy isoflavones include edamame, tofu, tempeh, and miso. Supplements standardised to genistein or total isoflavone content are also available.
Red Clover Isoflavones: The Evidence
Red clover (Trifolium pratense) contains a broader range of isoflavones than soy: genistein, daidzein, formononetin, and biochanin A. The presence of formononetin and biochanin A, which are not found in soy, means red clover has a slightly different binding profile at oestrogen receptors. Clinical trials, including those using the standardised Promensil supplement, suggest red clover isoflavones reduce hot flash frequency by a similar margin to soy, with some trials showing slightly higher reductions. Red clover has also shown promise for cardiovascular markers and arterial flexibility. The evidence base for red clover is somewhat smaller than for soy, but the results are generally consistent.
Comparing the Two Directly
Soy and red clover isoflavones are more similar than different in terms of clinical outcomes. Both produce modest reductions in hot flash frequency, neither matches the efficacy of HRT, and both appear safe for general use in healthy women. Red clover's broader isoflavone profile may give it a slight edge for cardiovascular markers, while soy has a larger body of research overall. Individual response varies considerably because of differences in gut microbiome composition, particularly around equol production. Women who are equol producers tend to respond better to both soy and red clover isoflavones. There is no reliable way to know whether you are an equol producer without specialised testing.
Safety and Who Should Be Cautious
Both soy and red clover isoflavones have a reassuring safety profile for most women. Despite early concerns that phytoestrogens might stimulate oestrogen-sensitive cancers, the weight of evidence does not support this for soy at dietary and supplemental doses in healthy women. Red clover similarly has not shown evidence of harm in short-term trials. However, women with a personal history of oestrogen-receptor-positive breast cancer are generally advised to discuss phytoestrogen use with their oncologist before starting. Women taking tamoxifen or other hormone-related medications should also seek guidance. Long-term safety data beyond two years remains limited for both, so it is reasonable to use them at the lowest effective dose.
Practical Guidance on Doses and Forms
For soy isoflavones, typical supplemental doses used in trials range from 40 to 80 mg of total isoflavones per day, standardised to genistein content. For red clover, standardised extracts providing around 40 to 80 mg of total isoflavones have been most studied. Both are generally taken once daily with food. It typically takes six to twelve weeks to see the full benefit, so short-term trials are not reliable indicators of whether the supplement is working. Some women prefer to get their soy isoflavones through diet rather than supplements, which is a reasonable approach if whole soy foods can be incorporated regularly. Red clover is less available as a food and is almost always taken as a supplement.
Making the Choice
If you have easy access to soy foods and want to combine dietary and supplemental sources, soy isoflavones may be the more practical starting point. If you are looking for a supplement with a slightly broader isoflavone profile and prefer to avoid soy for personal or dietary reasons, red clover is a solid evidence-based alternative. Either way, set realistic expectations: phytoestrogens help some women noticeably, particularly those with milder hot flashes, but are unlikely to provide the same relief as HRT for severe symptoms. PeriPlan can help you track symptom frequency and intensity before and after starting a supplement so you can assess whether it is making a meaningful difference.
Related reading
Get your personalized daily plan
Track symptoms, match workouts to your day type, and build a routine that adapts with you through every phase of perimenopause.